Questions? Call 800-624-6242 About | Ordering | New Menu | Items in cart [0] SEARCH

PAPERBACK price:$31.75 add to cart Rights & Permissions Free PDF Access Sign in to download PDF book and chapters Free Resources PDF SUMMARY Display this book on your site! Related Titles Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020: Workshop Summary Redesigning the Clinical Effectiveness Research Paradigm:Innovation and Practice-Based Approaches: Workshop Summary Other Related Titles Developing a National Registry of Pharmacologic and Biologic Clinical Trials: Workshop Report (2006) Board on Health Sciences Policy (HSP) Citation Manager Export the bibliographic data for this book in your chosen format Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Citation Manager . "Appendix F Illustrative Data Fields for the Results Summary." Developing a National Registry of Pharmacologic and Biologic Clinical Trials: Workshop Report. Washington, DC: The National Academies Press, 2006. Please select a format: Page 95   E-mail Share on facebook Facebook Share on delicious Delicious Share on stumbleupon Stumble Share on twitter Twitter More Sharing ServicesMore The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. F Illustrative Data Fields for the Results Summary (based on ICH E3 template*) Page 95 Front Matter (R1-R20) 1 Summary (1-4) 2 The Need for Clinical Trial Registries (5-8) 3 Current Registry Activities (9-18) 4 Content of a Clinical Trial Registry (19-34) 5 Implementation Issues (35-42) 6 Conclusion and Next Steps (43-46) References (47-48) Appendix A Participants and Invited Experts - Between December 1, 2004 and June 27, 2005 (49-50) Appendix B Workshop Agenda, Speakers, Panelists, and Participants - June 27, 2005 (51-62) Appendix C Sec. 113 of the Food and Drug Administration Modernization Act of 1997; Guidance for Industry: Information Programs on Clinical Trials... (63-80) Appendix D Published Journal Editorials (81-90) Appendix E Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases (91-94) Appendix F Illustrative Data Fields for the Results Summary (95-96) Appendix G Biographical Sketches of Committee Members (97-104)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 95
Developing a National Registry of Pharmacologic and Biologic Clinical Trials: Workshop Summary F Illustrative Data Fields for the Results Summary (based on ICH E3 template*)

OCR for page 96
Developing a National Registry of Pharmacologic and Biologic Clinical Trials: Workshop Summary *   Based on the ICH E3 template in the Food and Drug Administration (FDA) report, Guideline for Industry Structure and Content of Clinical Study Reports, July 1996.

Representative terms from entire chapter:

fda report